Back

Short-term risk of falls among initiators of controlled-release tapentadol versus oxycodone: A population-based cohort study

2026-01-16 public and global health Title + abstract only
View on medRxiv
Show abstract

ObjectiveGiven the potential severity and economic burden of falls, we compared the short-term risk of falls following initiation of sustained-release (SR) tapentadol versus controlled-release (CR) oxycodone in real-world clinical practice. DesignActive comparator, new user retrospective cohort study using routinely collected health data from 2014 to 2020. SettingNew South Wales, Australia. ParticipantsPeople aged [≥]18 years initiating publicly subsidised tapentadol (SR) or oxycodone (CR)...

Predicted journal destinations